These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development and characterization of monoclonal antibodies reactive with paraquat. Nagao M; Takatori T; Wu B; Terazawa K; Gotouda H; Akabane H J Immunoassay; 1989; 10(1):1-17. PubMed ID: 2715345 [TBL] [Abstract][Full Text] [Related]
3. The development of mouse monoclonal antibodies that bind and neutralize paraquat. Wright AF; Green TP; Smith LL Dev Biol Stand; 1987; 66():495-501. PubMed ID: 3582772 [TBL] [Abstract][Full Text] [Related]
4. Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies. Zanella I; Verardi R; Negrini R; Osio L; Albertini A; Ghielmi S Year Immunol; 1993; 7():213-9. PubMed ID: 8396821 [No Abstract] [Full Text] [Related]
6. Hybridomas and monoclonal antibodies: applications in oncology. Zalcberg JR; McKenzie IF Aust N Z J Surg; 1982 Aug; 52(4):431-8. PubMed ID: 7052043 [No Abstract] [Full Text] [Related]
7. Affinity-based precipitation via a bivalent peptidic hapten for the purification of monoclonal antibodies. Handlogten MW; Stefanick JF; Deak PE; Bilgicer B Analyst; 2014 Sep; 139(17):4247-55. PubMed ID: 25006715 [TBL] [Abstract][Full Text] [Related]
8. Rat monoclonal antibodies. I. Rapid purification from in vitro culture supernatants. Bazin H; Xhurdebise LM; Burtonboy G; Lebacq AM; De Clercq L; Cormont F J Immunol Methods; 1984 Feb; 66(2):261-9. PubMed ID: 6418823 [TBL] [Abstract][Full Text] [Related]
9. Screening strategies for catalytic antitransition-state analog antibodies. Tramontano A Methods Mol Biol; 1995; 51():237-50. PubMed ID: 7581701 [No Abstract] [Full Text] [Related]
13. Rapid development of affinity matured monoclonal antibodies using RIMMS. Kilpatrick KE; Wring SA; Walker DH; Macklin MD; Payne JA; Su JL; Champion BR; Caterson B; McIntyre GD Hybridoma; 1997 Aug; 16(4):381-9. PubMed ID: 9309429 [TBL] [Abstract][Full Text] [Related]
14. Novel approaches to the preparation and use of monoclonal antibodies. Lemieux R; Bazin R Transfus Med Rev; 1993 Jan; 7(1):25-36. PubMed ID: 8381687 [No Abstract] [Full Text] [Related]
15. Production of human monoclonal antibodies: potential therapeutic use in gut-derived infectious-toxic shock syndromes. Waelti ER; Stucki M Curr Stud Hematol Blood Transfus; 1992; (59):324-47. PubMed ID: 1315241 [No Abstract] [Full Text] [Related]
16. Chemical nature of mouse antibodies homologous to the 3-pyridylazo group: the fine specificities of hybridoma and serum antibodies. Johnson G; Jou YH; Krasner J; Pressman D Mol Immunol; 1982 Jul; 19(7):847-55. PubMed ID: 7121467 [TBL] [Abstract][Full Text] [Related]
17. Affinity purification of monoclonal antibodies, using a bifunctional oligosaccharide hapten. Uppugunduri S; Dakour J; Kallin E; Norberg T; Zopf D; Lundblad A Glycoconj J; 1991 Apr; 8(2):102-7. PubMed ID: 1823613 [TBL] [Abstract][Full Text] [Related]
18. Purification of mouse monoclonal antibodies from ascitic fluid by DEAE Affi-Gel Blue chromatography. Bruck C; Drebin JA; Glineur C; Portetelle D Methods Enzymol; 1986; 121():587-96. PubMed ID: 3724490 [No Abstract] [Full Text] [Related]
19. [Monoclonal antibodies : application of B cell hybridomas to biochemical research (author's transl)]. Tanaka S Tanpakushitsu Kakusan Koso; 1981 Jul; 26(8):965-76. PubMed ID: 7031777 [No Abstract] [Full Text] [Related]
20. Characterization of four murine monoclonal antibodies recognizing respectively HLA-A2 plus Aw69, HLA-B13, HLA-Bw4 and HLA-A28. Xu X; Wang C; Li Q; D'Alfonso S; Pozzi C; Richiardi P Tissue Antigens; 1990 Feb; 35(2):101-2. PubMed ID: 2343451 [No Abstract] [Full Text] [Related] [Next] [New Search]